AD-O53.2

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAD-O53.2
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInhibitor of apoptosis protein 3 modulatorsTumor necrosis factor ligand superfamily member 10 modulators
TargetsInhibitor of apoptosis protein 3Tumor necrosis factor ligand superfamily member 10
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A